BEATRIZ MATEUS: Open Payments
NPI 1417021486 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| Alkermes, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: CAPLYTA, INGREZZA, INVEGA SUSTENNA, ARISTADA, UZEDY, REXULTI, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
